Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
therapeutics symbols : Tgtx save search
TG Therapeutics Announces Additional Data Presentations for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-18 (Crawled : 12:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -0.43%
H: 4.57%
C: 0.0%
briumvi neurology sclerosis for meeting therapeutics
TG Therapeutics Awarded National Contract by the Department of Veterans Affairs for BRIUMVI as the Preferred Anti-CD20 for Relapsing Forms of Multiple Sclerosis
Published: 2024-04-18 (Crawled : 11:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -0.43%
H: 4.57%
C: 0.0%
cd20 briumvi contract sclerosis for therapeutics
TG Therapeutics Announces Presentation of Data for BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-04-15 (Crawled : 12:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -3.94%
H: 3.0%
C: -0.57%
briumvi neurology presentation sclerosis for meeting therapeutics
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.91 0.0% 1.4M
|
Health Technology
|
| O: 1.58%
H: 0.58%
C: -0.39%
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.4%
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 0.71%
H: 0.39%
C: 0.13%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 0.39%
H: 4.22%
C: 1.41%
precision business year update financial results
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2024 Annual Meeting
Published: 2024-03-08 (Crawled : 12:30) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 1.17%
H: 0.44%
C: -7.85%
briumvi sclerosis meeting therapeutics
TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2024-03-01 (Crawled : 12:30) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 1.86%
H: 4.79%
C: 2.39%
briumvi presentation sclerosis treatment research therapeutics
TG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2023 Financial Results
Published: 2024-02-28 (Crawled : 12:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 16.32%
H: 16.75%
C: 8.96%
business update therapeutics financial results
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)Newly issued patents extend exclusivity of ublituximab through 2042
Published: 2024-02-27 (Crawled : 14:30) - biospace.com/
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 3.44%
H: 1.77%
C: 0.65%
briumvi therapeutics
TG Therapeutics Announces Issuance of Additional Patents for BRIUMVI® (ublituximab-xiiy)
Published: 2024-02-27 (Crawled : 12:30) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 3.44%
H: 1.77%
C: 0.65%
briumvi therapeutics
TG Therapeutics Announces European Launch of BRIUMVI® (ublituximab-xiiy)
Published: 2024-02-26 (Crawled : 12:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 1.35%
H: 1.67%
C: -1.04%
briumvi therapeutics
TG Therapeutics to Host Conference Call on Fourth Quarter and Year-End 2023 Financial Results and Business Update
Published: 2024-02-23 (Crawled : 12:30) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -0.6%
H: 1.5%
C: -0.3%
conference business update therapeutics financial results
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
Published: 2024-02-20 (Crawled : 12:30) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -0.58%
H: 0.76%
C: -3.78%
briumvi sclerosis treatment research therapeutics
Precision BioSciences Receives Initial $7.5 Million Cash Payment and Equity Investment from TG Therapeutics for Azel-Cel in Treatment of Autoimmune Diseases
Published: 2024-02-12 (Crawled : 13:30) - biospace.com/
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 1.15%
H: 1.88%
C: 1.81%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 1.56%
H: 3.51%
C: -3.82%
precision million payment treatment therapeutics
Gene Therapy Global Market is Projected to Grow at a CAGR of ~19% by 2028, Predicts DelveInsight
Published: 2024-01-12 (Crawled : 22:00) - prnewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
| Email alert
Add to watchlist
VRTX | News | $393.51 0.1% 0.1% 950K
|
Health Technology
| Email alert
Add to watchlist
RARE F | $43.38 -1.65% -1.68% 770K
|
Health Technology
| Email alert
Add to watchlist
SLDB | $9.24 -7.51% -8.12% 140K
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
| Email alert
Add to watchlist
LLY | $745.95 -0.64% -0.81% 1.3M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | $93.6375 6.88% 82K
|
Health Technology
| Email alert
Add to watchlist
BLUE | $0.9583 -0.52% -0.52% 6.5M
|
Health Technology
| Email alert
Add to watchlist
NVS | $92.57 -0.55% 0.0% 910K
|
Health Technology
| Email alert
Add to watchlist
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
| Email alert
Add to watchlist
global therapy market
TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2023 Net Revenue and 2024 Anticipated Milestones
Published: 2024-01-10 (Crawled : 12:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 7.33%
H: 0.53%
C: -21.2%
year revenue therapeutics
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
Published: 2024-01-09 (Crawled : 13:30) - biospace.com/
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -8.22%
H: 9.05%
C: 7.47%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 10.0%
H: 14.23%
C: 0.09%
license cell treatment deal therapeutics therapy
TG Therapeutics Announces Global License Agreement with Precision BioSciences for the Development and Commercialization of Precision’s Allogeneic CD19 CAR T Cell Therapy Program for the Treatment of Autoimmune Diseases
Published: 2024-01-09 (Crawled : 12:00) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -8.22%
H: 9.05%
C: 7.47%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 10.0%
H: 14.23%
C: 0.09%
cd19 license cell treatment global commercialization program therapeutics agreement therapy
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare ConferencePresentation scheduled for Tuesday, January 9, 2024, at 4:30 PM PT
Published: 2024-01-05 (Crawled : 13:30) - biospace.com/
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -2.5%
H: 12.69%
C: 11.84%
therapeutics
TG Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-05 (Crawled : 12:30) - globenewswire.com
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -2.5%
H: 12.69%
C: 11.84%
conference therapeutics
TG Therapeutics to Participate in the 6th Annual Evercore ISI HealthCONx ConferenceFireside chat scheduled for Wednesday, November 29, 2023, at 2:10 PM ET
Published: 2023-11-27 (Crawled : 14:00) - biospace.com/
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -1.06%
H: 1.52%
C: 0.2%
therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.